Generic Name and Formulations:
Quadrivalent, inactivated, "subunit" influenza vaccine (virus types A and B); contains a total of 60mcg of hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; antibiotic-free.
<4yrs: not established. Each dose is 0.5mL by IM inj once in the deltoid. 4–8yrs: 1 or 2 doses at least 4wks apart (depending on vaccination history as per annual ACIP recommendation). ≥9yrs: 1 dose.
Use current formulation only. Have appropriate medical treatment and supervision readily available. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Pregnancy (Cat.B). Nursing mothers.
Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants: may get suboptimal response.
Local reactions (eg, pain, erythema, induration), headache, fatigue, myalgia; syncope.
Single-dose prefilled syringe 0.5mL (preservative-free)—10 (without needles); Multi-dose vial 5mL (contains thimerosal)—1
Join MIMS Learning now to manage all your CPD and notes in one place!
Already a MIMS Learning member?Sign In Now »
This red flags article explains signs and symptoms of potentially serious pathology in patients presenting...
This article by Dr Tillmann Jacobi covers the possible red flag symptoms to consider when a patient...
Dr Suneeta Kochhar provides an overview of red flag symptoms in patients presenting with headaches...
In this article, Dr David Brass and Dr Neil Rajan discuss the risk factors for BCC, making the diagnosis...
This article by Dr Rajiv Sankaranarayanan covers the diagnosis and management of cardiomyopathy. Key...
Dr Benjamin Simpson provides an in-depth overview of Parkinson’s disease, including information on risk...